Targeted degradation of aberrant tau in frontotemporal dementia patient-derived neuronal cell models | eLife
P-tau subgroups in AD relate to distinct amyloid production and synaptic integrity profiles | Alzheimer's Research & Therapy | Full Text
Levels of phospho-tau (P-tau; antibodies AT8 and PHF13) and total tau... | Download Scientific Diagram
Amyloid β and tau are involved in sleep disorder in Alzheimer's disease by orexin A and adenosine A(1) receptor
Phosphorylated tau targeted small-molecule PROTACs for the treatment of Alzheimer's disease and tauopathies - ScienceDirect
Amyloid-associated increases in soluble tau is a key driver in accumulation of tau aggregates and cognitive decline in early Alzheimer | medRxiv
Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's disease - eBioMedicine
Polymerization of hyperphosphorylated tau into filaments eliminates its inhibitory activity | PNAS
STZ effect on p-tau in hippocampus. (a) Representative immunoblots of... | Download Scientific Diagram
Phospho-tau/tau Ratios: Better Markers than Absolute p-Tau Levels? | ALZFORUM
Proline Isomer-Specific Antibodies Reveal the Early Pathogenic Tau Conformation in Alzheimer's Disease - ScienceDirect
Fluorescence Lifetime Imaging of p-tau Protein in Single Neuron with a Highly Selective Fluorescent Probe | Analytical Chemistry
Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia | Nature Medicine
Synergistic Association between Plasma Aβ1–42 and p-tau in Alzheimer's Disease but Not in Parkinson's Disease or Frontotemporal Dementia | ACS Chemical Neuroscience
JCI - CHIP-ping away at tau
Disrupted ubiquitin proteasome system underlying tau accumulation in Alzheimer's disease - ScienceDirect
Cis P-tau underlies vascular contribution to cognitive impairment and dementia and can be effectively targeted by immunotherapy in mice | Science Translational Medicine
Approach - Pinteon Therapeutics
Biomarkers in Alzheimer's disease
IJMS | Free Full-Text | Phosphorylated Tau in Alzheimer’s Disease and Other Tauopathies
Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study - The Lancet Neurology
Frontiers | Tau: A Signaling Hub Protein
Targeted Dephosphorylation of Tau by Phosphorylation Targeting Chimeras (PhosTACs) as a Therapeutic Modality | Journal of the American Chemical Society
Cis P-tau in the CSF of severe TBI patients is neurotoxic and... | Download Scientific Diagram
